Cambridge, United Kingdom

Piotr Antoni Raubo

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • Loughborough, GB (2011)
  • Macclesfield, GB (2012)
  • Leicestershire, GB (2011 - 2014)
  • Cambridge, GB (2018 - 2019)

Company Filing History:


Years Active: 2011-2019

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Piotr Antoni Raubo in Cancer Treatment

Introduction

Piotr Antoni Raubo is a prominent inventor located in Cambridge, GB, known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 8 patents, his work primarily focuses on innovative compounds that show promise in treating various cancers. Raubo's inventions reflect a commitment to advancing medical science and providing novel therapeutic options.

Latest Patents

One of Raubo's latest notable patents involves the development of 1,3,4-thiadiazole compounds and their potential use in treating cancer. The specification outlines the compounds of Formula (I) and their pharmaceutically acceptable salts. These compounds are designed to treat or prevent GLS1 mediated diseases, including cancer. Additionally, Raubo's patent includes information on crystalline forms of these compounds, pharmaceutical compositions that incorporate them, and methods of manufacture. This innovation also details methods for treating GLS1 kinase mediated diseases utilizing these novel compounds, showcasing his dedication to combating cancer through innovative chemical solutions.

Career Highlights

Raubo's career has been marked by significant roles within prestigious companies. He has worked with AstraZeneca and Cancer Research Technology Limited, where he has played a pivotal role in research and development efforts aimed at creating effective cancer treatments. His focus on practical applications of his scientific research has led to impactful advancements in the field.

Collaborations

Throughout his career, Piotr has collaborated with esteemed colleagues in the industry. Notable collaborators include Richard Evans and Maurice Raymond Verschoyle Finlay, with whom he has shared insights and expertise, contributing to the successful development of therapeutic innovations.

Conclusion

Piotr Antoni Raubo's work exemplifies the spirit of innovation in the pharmaceutical industry, particularly in the battle against cancer. Through his patents and collaborations, he continues to push the boundaries of medical research and is poised to make lasting impacts in the treatment of GLS1 mediated diseases. His contributions are a testament to the vital role inventors play in the advancement of healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…